Lord, Abbett & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-287,946
| Closed | -$20.1M | – | 659 |
|
|
2022
Q3 | $20.1M | Sell |
287,946
-25,349
| -8% | -$1.77M | 0.07% | 329 |
|
|
2022
Q2 | $21M | Buy |
313,295
+5,010
| +2% | +$336K | 0.07% | 326 |
|
|
2022
Q1 | $25.3M | Sell |
308,285
-189,155
| -38% | -$15.6M | 0.07% | 342 |
|
|
2021
Q4 | $73M | Buy |
497,440
+23,349
| +5% | +$3.43M | 0.17% | 191 |
|
|
2021
Q3 | $83.9M | Buy |
474,091
+116,561
| +33% | +$20.6M | 0.2% | 160 |
|
|
2021
Q2 | $57.8M | Sell |
357,530
-262,793
| -42% | -$42.4M | 0.14% | 224 |
|
|
2021
Q1 | $106M | Sell |
620,323
-139,798
| -18% | -$23.9M | 0.27% | 107 |
|
|
2020
Q4 | $167M | Buy |
760,121
+364,634
| +92% | +$80.1M | 0.44% | 47 |
|
|
2020
Q3 | $65.7M | Sell |
395,487
-253,968
| -39% | -$42.2M | 0.21% | 141 |
|
|
2020
Q2 | $74.1M | Sell |
649,455
-20,810
| -3% | -$2.38M | 0.26% | 112 |
|
|
2020
Q1 | $51.5M | Sell |
670,265
-47,294
| -7% | -$3.64M | 0.23% | 130 |
|
|
2019
Q4 | $92.5M | Buy |
717,559
+331,376
| +86% | +$42.7M | 0.31% | 93 |
|
|
2019
Q3 | $30.1M | Buy |
386,183
+9,492
| +3% | +$740K | 0.1% | 325 |
|
|
2019
Q2 | $38.8M | Sell |
376,691
-253,693
| -40% | -$26.1M | 0.13% | 274 |
|
|
2019
Q1 | $46.2M | Buy |
630,384
+364,005
| +137% | +$26.7M | 0.15% | 218 |
|
|
2018
Q4 | $11.3M | Buy |
266,379
+6,486
| +2% | +$275K | 0.04% | 508 |
|
|
2018
Q3 | $12.2M | Buy |
+259,893
| New | +$12.2M | 0.03% | 589 |
|
|
2015
Q3 | – | Sell |
-162,506
| Closed | -$5.11M | – | 974 |
|
|
2015
Q2 | $5.11M | Buy |
+162,506
| New | +$5.11M | 0.01% | 765 |
|